BCRX
BioCrystBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The bull case is that BioCryst has moved from a single-product commercialization story toward a broader HAE platform: 2025 ORLADEYO revenue reached $601.8 million, 2026 ORLADEYO guidance was maintained at $625 million to $645 million, profitability improved, pediatric expansion added reach, and navenibart gives the company a potentially differentiated long-acting prophylaxis asset. [#8-K-2026-02-26] [#10-K-2026-02-26]
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -0.7.
What can break
BCX17725 is still an early Phase 1 program, so proof-of-concept and commercial relevance remain uncertain. [#8-K-2026-02-26]
Momentum
52
Value
61
Sentiment
72
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $10.50 · Bull $13.50 · Bear $6.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-28 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $21.30
Why
Momentum52 · Δ7d +5.6
Value61 · Δ7d +0.1
Sentiment72 · Δ7d -0.7
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Sentiment · See AI snapshot
Momentum
52
34% active weight
Current posture
7d trendSoftening
Δ7d
+5.6
Δ21d
+10.7
Value
61
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.4
Sentiment
72
33% active weight
Current posture
7d trendFlat
Δ7d
-0.7
Δ21d
+9.0
Why this grade
Composite grade B. Momentum 52.0 / Value 60.9 / Sentiment 72.1
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$2.18B
Beta
0.83
Shares Out
210.74M
P/E (TTM) · Derived
8.2
P/S (TTM)
2.60
P/FCF (TTM)
47.30
Rev YoY
+36.1%
EPS YoY
+186.5%
Gross Margin
+97.4%
Op Margin
+11.5%
Net Debt
$511.71M
Current Ratio
1.87
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology